🔗 Permalink

Inventor profile of:

Hakon Leffler

City:

Lund

Country:

Sweden

Published Applications:

24

Last publication date:

2022-09-15

Top Assignees for applications by Hakon Leffler

The entities that hold a legal rights for patent applications filed by inventor Leffler Hakon:

GALECTO BIOTECH AB 17 Copenhagen, Denmark
FORSKARPATENT I SYD AB 3 Lund, Sweden
GALECTO BIOTECH AB 2 Lund, Sweden
Galecto Biotech AB 1 Cobis, Denmark
Galecto Biotech AB 1 Copenhagen, Germany

Recent patent applications by Leffler Hakon

Hakon Leffler from Lund, SE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-09-15

US20220289783A1

Chemistry; metallurgy

Galactoside inhibitor of galectins

#2 | 2021-07-22

US20210221836A1

Chemistry; metallurgy

IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS

#3 | 2020-12-31

US20200407391A1

Chemistry; metallurgy

Galactoside inhibitor of galectins

#4 | 2020-04-16

US20200115410A1

Chemistry; metallurgy

Hybrid galactoside inhibitor of galectins

#5 | 2019-12-12

US20190375776A1

Chemistry; metallurgy

IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS

#6 | 2019-11-28

US20190359643A1

Chemistry; metallurgy

Galactoside inhibitor of galectins

#7 | 2019-10-17

US20190315793A1

Chemistry; metallurgy

Alpha-D-galactoside inhibitors of galectins

#8 | 2019-07-25

US20190225638A1

Chemistry; metallurgy

Alpha-D-galactoside inhibitors of galectins

#9 | 2018-11-15

US20180327440A1

Chemistry; metallurgy

1,1 ′-sulfanediyl-di-beta-D-galactopyranosides as inhibitors of galectins

#10 | 2017-12-07

US20170349622A1

Chemistry; metallurgy

Hybrid galactoside inhibitor of galectins

#11 | 2017-12-07

US20170349619A1

Chemistry; metallurgy

Galactoside inhibitor of galectins

#12 | 2017-11-23

US20170334940A1

Chemistry; metallurgy

Galactoside inhibitor of galectins

#13 | 2017-09-28

US20170275326A1

Chemistry; metallurgy

IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS

#14 | 2017-04-06

US20170095496A1

Human necessities

GALACTOSIDE INHIBITORS FOR NEW USES

#15 | 2016-04-07

US20160096861A1

Chemistry; metallurgy

Galactoside inhibitor of galectins

#16 | 2015-11-12

US20150320782A1

Human necessities

Methods, compositions and kits for treating, modulating, or preventing ocular angiogenesis or fibrosis in a subject using a galectin protein inhibitor

#17 | 2015-10-01

US20150274764A1

Chemistry; metallurgy

Galactoside inhibitor of galectin-3 and its use for treating pulmonary fibrosis

#18 | 2014-11-13

US20140336146A1

Chemistry; metallurgy

Galectoside inhibitors of galectins

#19 | 2014-07-17

US20140200190A1

Chemistry; metallurgy

NOVEL GALACTOSIDE INHIBITORS OF GALECTINS

#20 | 2014-05-01

US20140121179A1

Chemistry; metallurgy

Galactoside inhibitor of galectins

#21 | 2012-06-28

US20120165277A1

Chemistry; metallurgy

Galactoside inhibitors of galectins

#22 | 2007-08-09

US20070185041A1

Chemistry; metallurgy

3-triazolyl-galactoside inhibitors of galectins

#23 | 2007-08-09

US20070185039A1

Chemistry; metallurgy

Galactoside inhibitors of galectins

#24 | 2005-02-10

US20050032673A1

Chemistry; metallurgy

Sustained release N-terminally truncated galectin-3 and antibodies to galectin-3 carbohydrate ligands for use in treating disease

InventorID:

746305 ⎘